Applied Biosciences Corp. (APPB) Research

Applied Biosciences Corp. is dedicated to the creation and market launch of synthetic cannabinoid biopharmaceutical treatments. These advanced therapeutics are specifically designed to interact with the body's endocannabinoid system, aiming to address a wide array of diseases across diverse medical specialties. Furthermore, the company offers over-the-counter, THC-free CBD products directly to consumers, which are intended to support general health and well-being. It also provides specialized testing and analytical services to its customers. The firm was founded in 2014 and operates from its base in Beverly Hills, California.

Market snapshot

Symbol
APPB
Price
$0.00
Day change
0.00%
Market cap
$1.4K
P/E ratio
-0.00x
52-week range
0.0001-0.0002
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Allied Corp. (ALID)
  • Bionoid Pharma, Inc. (BINP)
  • Target Group Inc. (CBDY)
  • Cann American Corp. (CNNA)
  • CannaPharmaRX, Inc. (CPMD)
  • Anything Technologies Media, Inc. (EXMT)
  • Yooma Wellness Inc. (LVVEF)
  • MJardin Group, Inc. (MJARF)

Recent insider activity

  • Beaubaire Michael — trade (0 shares) on 2019-10-03
  • Brady John Robert — A-Award (100000 shares) on 2019-09-13
  • Urbanski Raymond W. — trade (0 shares) on 2019-05-28
  • Urbanski Raymond W. — trade (0 shares) on 2019-05-28
  • Stevens Scott B — trade (0 shares) on 2019-04-15

Open Applied Biosciences Corp. (APPB) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.